Add like
Add dislike
Add to saved papers

Subfoveal Nodule Affecting Visual Prognosis in Coats' Disease.

PURPOSE: To investigate the characteristics of subfoveal nodules in Korean patients with Coats' disease and their association with visual outcomes Method: A retrospective analysis was conducted within the medical records of patients with Stage 2B or 3A1 Coats' disease, including clinical features, imaging, presence of either a subfoveal nodule or macular fibrosis, and visual outcome.

RESULTS: Twelve patients were present with Stage 2B or 3A1 Coats' disease, and 9 patients (75%) presented with subfoveal nodule. Between the group without subfoveal nodule and the group with subfoveal nodule, there were no significant differences in age (mean, 14.0±1.7 years vs 27.7 ± 21.8, P=0.482), sex (all males), stage of the disease (2B; 3 patients vs 8 patients, P=1.000, 3A1; 0 patient vs 1 patient, P=1.000), extension of retinal exudation (mean 7.7 hours vs 4.1 hours, P=0.209) and peripheral telangiectasia (mean, 3.7 hours vs 4.2 hours, P=0.727), and follow-up duration (mean, 65 months vs 46.1 months, P=0.600). There were significantly more patients with severe visual loss (≤20/200) among the patients with subfoveal nodule (0 patient vs 7 patients, P=0.045), and the cause for severe visual loss was macular fibrosis in all cases. Macular fibrosis developed significantly more frequently in the patients with subfoveal nodule (0 patient vs 7 patients, P=0.045).

CONCLUSION: This study is the first study covering the analysis of subfoveal nodules in Korean patients with Coats' disease. The existence of a subfoveal nodule at the initial diagnosis serves as an indicator predicting the development of macular fibrosis and a less favorable visual outcome in the patients with Coats' disease. A multi-center study with a larger patient pool and further studies toward the therapeutic approach for the subfoveal nodule and macular fibrosis are needed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app